Institut Curie
Clinical trials sponsored by Institut Curie, explained in plain language.
-
After thymoma surgery: zap it or watch it?
Disease control Recruiting nowThis study aims to find out if giving radiation therapy after successful surgery for stage II or III thymoma helps prevent the cancer from coming back better than just regular monitoring. It will enroll about 314 adults who have had their thymoma completely removed. Participants …
Phase: NA • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Genetic test aims to match pancreatic cancer patients with best chemo
Disease control Recruiting nowThis study is testing a personalized approach to choose the first chemotherapy for people with advanced pancreatic cancer that has spread. Doctors will analyze the genetic makeup of a patient's tumor biopsy to predict which of two standard chemotherapy combinations might work bet…
Phase: NA • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for saving Children's eyes from cancer
Disease control Recruiting nowThis study is testing two different approaches to treat retinoblastoma, a rare eye cancer in children, while trying to save the affected eye and preserve vision. One part compares two chemotherapy methods delivered directly to the eye, while another part evaluates vision outcomes…
Phase: PHASE2, PHASE3 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scans and blood tests aim to pick best next treatment for breast cancer
Disease control Recruiting nowThis trial aims to help doctors choose the most effective second treatment for people with advanced breast cancer that has stopped responding to initial hormone therapy. It uses special scans and blood tests to guide whether patients should receive more hormone-based treatments o…
Phase: PHASE3 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New hope for Tough-to-Treat breast cancer: Two-Drug attack targets hidden weakness
Disease control Recruiting nowThis study is testing whether a combination of two existing drugs, tucatinib and trastuzumab, can help control advanced breast cancer that has a specific genetic mutation (called HER3) but is not the usual HER2-positive type. It's for people whose cancer has grown despite trying …
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Lab-Grown 'Tumor Avatars' guide next chemo choice in groundbreaking trial
Disease control Recruiting nowThis study is testing a personalized method to help choose the next chemotherapy for patients with advanced breast cancer. Doctors take a small sample of a patient's tumor and grow it in the lab to create a 'tumor avatar.' They test different chemotherapy drugs on this avatar to …
Phase: NA • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Blood test trial aims to catch deadly breast Cancer's return before it spreads
Diagnosis Recruiting nowThis study is testing whether a new monitoring approach can find returning triple negative breast cancer earlier. It will track 450 women at high risk of their cancer coming back using regular blood tests that look for tiny pieces of tumor DNA. If the blood test turns positive, h…
Phase: NA • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
New scan aims to spot deadly pancreatic cancer sooner
Diagnosis Recruiting nowThis study is testing a new type of PET scan called FAPI PET to see if it can detect the return or spread of pancreatic cancer earlier than current standard scans like CT or MRI. It involves 35 patients who have already been diagnosed with non-metastatic pancreatic cancer and are…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Diagnosis
Last updated Mar 23, 2026 15:16 UTC
-
New solution tested to shield sick kids from dangerous infections
Prevention Recruiting nowThis study is testing if a special solution called taurolidine can prevent infections in the catheters used by children and young adults with cancer. Researchers will compare it to a standard saline solution to see which one better stops germs from growing inside the catheter. Th…
Phase: NA • Sponsor: Institut Curie • Aim: Prevention
Last updated Mar 25, 2026 14:08 UTC
-
New approach to surgery pain may reduce need for strong painkillers
Symptom relief Recruiting nowThis study is testing whether using anesthesia without opioids during breast reconstruction surgery leads to less need for morphine pain medication afterward. Researchers will compare two groups of patients: one receiving traditional opioid-based anesthesia and one receiving opio…
Phase: PHASE3 • Sponsor: Institut Curie • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC
-
Tracking eye Cancer's return: a search for early warning signs
Knowledge-focused Recruiting nowThis study aims to find better ways to monitor patients with high-risk uveal melanoma (a type of eye cancer) for signs that the cancer has spread to the liver. Researchers will follow 700 patients for up to 10 years, collecting regular MRI scans and blood samples to look for biol…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Apr 01, 2026 22:56 UTC
-
Blood test could tell doctors if cancer treatment is working
Knowledge-focused Recruiting nowThis study aims to see if simple blood tests can predict how well immunotherapy will work for people with advanced lung cancer. Researchers will track 300 patients receiving first-line immunotherapy, taking regular blood samples to look for cancer DNA and immune cell changes. The…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Apr 01, 2026 22:56 UTC
-
Scientists probe immune secrets of rare thymus tumors
Knowledge-focused Recruiting nowThis study aims to learn more about thymic epithelial tumors (TETs), a rare type of cancer. Researchers will collect tumor and blood samples from 50 patients undergoing surgery to analyze the immune cells and genetic features of these tumors. The goal is to build a detailed pictu…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Could a simple blood test replace cancer biopsies?
Knowledge-focused Recruiting nowThis study aims to learn if cancer markers found in blood samples can provide the same information as a traditional tissue biopsy. It will enroll 2,050 people already being treated for cancer to collect blood samples over time. The research is observational and will not change an…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Chemo port dressings causing widespread skin issues, major study launches
Knowledge-focused Recruiting nowThis study aims to understand how often and why skin reactions like redness and itching occur under the dressings that cover implanted chest ports used for chemotherapy. It will follow 500 new chemotherapy patients to measure the problem and look for links to factors like the typ…
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Scientists gather cancer clues to build future treatments
Knowledge-focused Recruiting nowThis study aims to collect and store tumor tissue and blood samples from patients with certain cancers. The goal is to better understand the relationship between a tumor's genetic makeup, its surrounding environment, and the body's immune response. Patients will receive standard …
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC
-
New scan could tell doctors if cancer treatment will work
Knowledge-focused Recruiting nowThis study is testing if a new type of PET scan can predict how well a patient's triple-negative breast cancer will respond to a standard combination of chemotherapy and immunotherapy before they even start treatment. Researchers will scan 60 patients with early-stage, high-risk …
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC
-
Study probes the hidden fear haunting cancer survivors
Knowledge-focused Recruiting nowThis study aims to understand how common and severe the fear of cancer returning is for people treated for breast or lung cancer. Researchers will survey 200 patients and conduct in-depth interviews to learn about their experiences and needs. The goal is to develop better tools t…
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:22 UTC